Dec 14 2022 23 mins 6
Drs Sparks and Bansal discuss the screening and treatment for CKD as a primary care physician, including testing, cardiovascular risk, new treatments, and when to refer a patient to a nephrologist.
Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/971889). The topics and discussions are planned, produced, and reviewed independently of advertiser. This podcast is intended only for US healthcare professionals.
Resources
Estimated GFR Can Widely Diverge From Measured GFR https://www.medscape.com/viewarticle/976533
Kidney Failure Risk Equation Works Without Race Adjustment https://www.medscape.com/viewarticle/966313
The Kidney Failure Risk Equation https://kidneyfailurerisk.com/
Don't Routinely Stop RAS Inhibitors in Advanced Kidney Disease https://www.medscape.com/viewarticle/943717
What Is the Role of Mineralocorticoid Receptor Antagonists (MRAs) in the Treatment of Proteinuria? https://www.medscape.com/answers/238158-93529/what-is-the-role-of-mineralocorticoid-receptor-antagonists-mras-in-the-treatment-of-proteinuria
What Is the Role of SGLT2 Inhibitors in the Treatment of Chronic Kidney Disease (CKD)? https://www.medscape.com/answers/238798-105205/what-is-the-role-of-sglt2-inhibitors-in-the-treatment-of-chronic-kidney-disease-ckd
Sodium-Glucose Cotransporter 2 Inhibitors: Safety Concerns https://www.medscape.com/viewarticle/892957_6
finerenone (Rx) https://reference.medscape.com/drug/kerendia-finerenone-4000168
Cardiovascular Disease in Chronic Kidney Disease https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.120.050686
